Our Europe Ventures team backs Patient21 which emerges from stealth after raising $142 million of investment

Patient21, the Berlin-based healthtech, was founded in 2020 by former Auto1 COO, Christopher Muhr. Patient21 is radically overhauling healthcare by building the most advanced digitally enabled healthcare system in Europe that will ensure every patient record is complete, up-to-date, and accessible. The company is delivering a ‘digi-physical’ platform that creates a seamlessly integrated patient experience. The goal is to enable healthcare professionals to significantly improve the quality of diagnosis using up-to-date patient data and delivering better care for lower cost.

The fast-growing healthtech, which has grown by more than 300% since 2020, operates 25 clinics in 19 cities across Germany and plans to expand across Europe over the next two years. Patient21 will be in every major healthcare market in the world by the end of the decade.

Mr. Muhr, widely regarded as one of Europe’s most respected entrepreneurs who has successfully launched and exited several high-profile tech companies such as Groupon and Auto1, which listed on the stock exchange in Frankfurt in February 2021, has turned his sights to revolutionize healthcare after undergoing cancer treatment.

Mr Muhr, CEO and founder of Patient21, said: “Patient21 was created as a result of my own experience when I was initially diagnosed with cancer. Throughout my treatment, I saw how incredibly difficult it was for the many knowledgeable healthcare professionals caring for me to have all the critical information about me in front of them. There are so many cogs in the healthcare wheel, which inevitably creates gaps and time delays, both of which can have a negative impact on the health and treatment of you as a patient.”

We're thrilled to have partnered with Patient21 and our friends at Target Global, Piton Capital, Pico Capital, Thomas Stafford, and Kingsway. We’re excited to work together as Patient21 scales across Europe.